James Perry
Overview
Explore the profile of James Perry including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
91
Citations
3065
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhong M, Onyenobi E, Duomatey A, Chen G, Perry J, Ye Z, et al.
Obesity (Silver Spring)
. 2024 Oct;
32(11):2175-2185.
PMID: 39351966
Objective: Understanding the genetic underpinnings of anthropometric traits in diverse populations is crucial for gaining insights into their biological mechanisms and potential implications for health. Methods: We conducted a genome-wide...
2.
Heyn C, Bishop J, Moody A, Kang T, Wong E, Howard P, et al.
AJNR Am J Neuroradiol
. 2024 Aug;
46(1):129-135.
PMID: 39107039
Background And Purpose: Differentiating radiation necrosis (RN) from tumor progression (TP) after radiation therapy for brain metastases is an important clinical problem requiring advanced imaging techniques that may not be...
3.
Lamba A, Roston T, Peltenburg P, Kallas D, Franciosi S, Lieve K, et al.
Heart Rhythm
. 2024 Apr;
21(10):1767-1776.
PMID: 38588993
Background: Catecholaminergic polymorphic ventricular tachycardia (CPVT) may cause sudden cardiac death (SCD) despite medical therapy. Therefore, implantable cardioverter-defibrillators (ICDs) are commonly advised. However, there is limited data on the outcomes...
4.
Ong W, Stewart J, Sahgal A, Soliman H, Tseng C, Detsky J, et al.
Int J Radiat Oncol Biol Phys
. 2024 Apr;
120(3):750-759.
PMID: 38561051
Purpose: We present the final analyses of tumor dynamics and their prognostic significance during a 6-week course of concurrent chemoradiotherapy for glioblastoma in the Glioblastoma Longitudinal Imaging Observational study. Methods...
5.
Roth P, Gorlia T, Reijneveld J, de Vos F, Idbaih A, Frenel J, et al.
Neuro Oncol
. 2024 Mar;
26(9):1670-1682.
PMID: 38502052
Background: Standard treatment for patients with newly diagnosed glioblastoma includes surgery, radiotherapy (RT), and temozolomide (TMZ) chemotherapy (TMZ/RT→TMZ). The proteasome has long been considered a promising therapeutic target because of...
6.
Moore-Palhares D, Chen H, Keith J, Wang M, Myrehaug S, Tseng C, et al.
J Neurooncol
. 2023 Jun;
163(3):553.
PMID: 37378836
No abstract available.
7.
Kingsmore S, Smith L, Kunard C, Bainbridge M, Batalov S, Benson W, et al.
Am J Hum Genet
. 2023 Jun;
110(6):1017.
PMID: 37267897
No abstract available.
8.
Moore-Palhares D, Chen H, Keith J, Wang M, Myrehaug S, Tseng C, et al.
J Neurooncol
. 2023 May;
163(3):541-551.
PMID: 37256526
Purpose: Recurrent high-grade glioma (rHGG) is a heterogeneous population, and the ideal patient selection for re-irradiation (re-RT) has yet to be established. This study aims to identify prognostic factors for...
9.
Jo J, Diaz M, Horbinski C, Mackman N, Bagley S, Broekman M, et al.
Neuro Oncol
. 2023 Apr;
25(8):1381-1394.
PMID: 37100086
Patients with diffuse glioma are at high risk of developing venous thromboembolism (VTE) over the course of the disease, with up to 30% incidence in patients with glioblastoma (GBM) and...
10.
Tseng C, Chen H, Stewart J, Lau A, Chan R, Lawrence L, et al.
Front Oncol
. 2022 Dec;
12:1060098.
PMID: 36518316
Purpose: This study reports the workflow and initial clinical experience of high grade glioma (HGG) radiotherapy on the 1.5 T MR-Linac (MRL), with a focus on the temporal variations of...